Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6015715 | Epilepsy Research | 2014 | 6 Pages |
â¢Efficacy and tolerability of EZG/RTG were assessed by class of adjunctive AED.â¢Mechanistic classes included sodium or non-sodium channel blockers, or â¥1 of each.â¢Mechanistic class of AED did not affect EZG/RTG efficacy or tolerability.
SummaryIntegrated data from three double-blind, randomized, placebo-controlled trials were analyzed to evaluate the efficacy and tolerability of ezogabine (EZG; US adopted name)/retigabine (RTG; international non-proprietary name) when used in combination with â¥1 sodium channel blocking antiepileptic drug (AED), â¥1 non-sodium channel blocking AED, or â¥1 AED from both the sodium channel and non-sodium channel mechanistic groups. Efficacy and tolerability appeared to be similar across all three groups of patients.